Navigation Links
Study Confirms Third Trimester Amniotic Fluid a Reliable Source of Stem Cells for Regenerative Medicine and Stem Cell Banking
Date:2/16/2011

MEDFORD, Mass., Feb. 16, 2011 /PRNewswire/ -- In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.

Amniotic fluid has emerged as one of the most attractive sources of mesenchymal stem cells with broad utility for stem cell therapy development. The stem cells contained in amniotic fluid are multifunctional and can grow into many different organs and tissues. Research shows that these stem cells could be used to repair cartilage in the knee, heal wounds or grow heart valves. There are 160 human clinical trials around the world evaluating cells similar to the ones found in amniotic fluid, and researchers predict innovations to continue.

"Amniotic fluid banking is the latest advance in stem cell preservation. Research with these stem cells is leading to significant medical discoveries, and the only way to take advantage is to plan ahead and preserve now," says Dr. Kate Torchilin, PhD, CEO of Biocell Center. "Additionally, a little bit of fluid can be easily collected during prenatal tests throughout pregnancy."

The study confirms that amniotic fluid collected during the third trimester contains mesenchymal stem cells that are similar to younger amniotic fluid cells collected earlier in pregnancy, and potentially enables many more pregnant women to save amniotic fluid.

Amniotic fluid preservation has been widely available in Europe for years, and is rapidly gaining traction in the US. Families banking amniotic fluid now can give their child many options for the future.

"I recommend that moms undergoing certain prenatal tests, such as amniocentesis, in the second or third trimester, discuss saving this fluid with their doctor as soon as they know they will be having an amnio," says Dr. Lucy Bayer, the chief Maternal Fetal Medicine Doctor at St. Elizabeth Hospital and one of the investigators for the study. "Additionally, I am very excited about these findings, as they affirm amniotic fluid as an excellent source of cells for tissue regeneration."

The study comes out just 2 weeks after the first national Amniotic Fluid Awareness Day that educated expecting families about the benefits of amniotic fluid beyond pregnancy.

For more information about Amniotic Fluid Awareness day or amniotic fluid banking, visit http://www.biocellcenter.com or call 1-866-246-2720.

About Amniotic Fluid Stem CellsAmniotic fluid contains fetal cells that are normally shed during growth, and other chemicals and substances. Amniotic fluid can provide important information about baby's health before birth.

About Biocell CenterBiocell Center, the leader in amniotic fluid preservation was founded by internationally renowned doctors and scientists with decades of experience in prenatal testing and stem cells. Biocell Center offers amniotic fluid cell cryopreservation services worldwide.MEDIA CONTACTS:GCI HealthAndrea FassacesiaPh: (212) 798-9942This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE Biocell Center
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Novartis Drug Afinitor® Extends Progression-Free Survival in Patients With Advanced Pancreatic NET, Study Published in NEJM Shows
2. New test to study proteins involved in neurodegenerative diseases
3. A new model for studying Parkinsons
4. Cephalon Announces Positive Topline Results From a Phase IV Study of NUVIGIL in Shift Work Disorder
5. Columbia University researchers use nanoscale transistors to study single-molecule interactions
6. New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels
7. New Johns Hopkins School of Medicine Study Shows Masimo Noninvasive Hemoglobin Monitoring is Accurate During Complex Spine Surgeries
8. Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal
9. Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy
10. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
11. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):